Together we will beat cancer

Donate
Blank Avatar

Tim is a senior digital news officer at Cancer Research UK. He started writing about science after studying English literature at Cambridge and magazine journalism at City, University of London. Before joining the digital news team in August 2022, he was a journalist and medical magazine editor.

Cancer Research UK appoints new Trustees and independent Committee Members

Cancer Research UK today announced the appointments of Rakshit Kapoor and Hitesh Thakrar to its Council of Trustees, the charity’s board of directors.

Read More

Time to take on 9 new Cancer Grand Challenges

These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.

Read More

Can cancer cells communicate?

Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too.

Read More

The ecDNA story – catching the mastermind behind cancer evolution

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we’re going to stop it.

Read More

Better together: improving brain tumour treatment

We’ve helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective.

Read More

Early-onset cancer: why are more young adults being diagnosed?

Cancer rates in adults under 50 have been rising since the 1990s. Our researchers are leading the effort to turn the trend around.

Read More

Chemo before surgery helps stop colon cancer coming back

Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded.

Read More

Our most important cancer research stories of 2022

This year has been full of research, advances and people worth celebrating. Here are some of our biggest stories from the past 12 months. 

Read More

NICE recommends pembrolizumab for 1,600 more people with breast cancer

The “potentially life-saving” immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.

Read More

The Nobel Prize winner helping us treat children’s cancers

Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She’s using all she’s learned to create better treatments for solid tumours in children.

Read More